Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy

Neuron

Volumn 75, Issue 3, 2012, Pages 437-450

  Charizanis, Konstantinos ^a   Lee, Kuang Yung ^a,b   Batra, Ranjan ^a   Goodwin, Marianne ^a   Zhang, Chaolin ^c   Yuan, Yuan ^c   Shiue, Lily ^d   Cline, Melissa ^d   Scotti, Marina M ^a   Xia, Guangbin ^a   Kumar, Ashok ^a   Ashizawa, Tetsuo ^a   Clark, H Brent ^e   Kimura, Takashi ^f   Takahashi, Masanori P ^g   Fujimura, Harutoshi ^h   Jinnai, Kenji ⁱ   Yoshikawa, Hiroo ^f   Gomes Pereira, Mário ^j   Gourdon, Geneviève ^j   Sakai, Noriaki ^k   Nishino, Seiji ^k   Foster, Thomas C ^a   Ares, Manuel ^d   Darnell, Robert B ^c   Swanson, Maurice S ^a   more..

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c ROCKEFELLER UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f HYOGO COLLEGE OF MEDICINE   (Japan)

^g OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h TONEYAMA NATIONAL HOSPITAL   (Japan)

ⁱ Japan   (Japan)

^j IMAGINE INSTITUTE   (France)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLEBLIND LIKE 2 PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENETIC REGULATION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MOUSE; MYOTONIC DYSTROPHY; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REM SLEEP; SLEEP DISORDER; SPATIAL MEMORY; SYNAPTIC TRANSMISSION;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYOTONIC DYSTROPHY; NEURONAL PLASTICITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SYNAPTIC TRANSMISSION;

EID: 84864912095     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2012.05.029     Document Type: Article

References (60)

1. Bailey T.L., Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 1994, 2:28-36.
2. Bennett E.J., Shaler T.A., Woodman B., Ryu K.Y., Zaitseva T.S., Becker C.H., Bates G.P., Schulman H., Kopito R.R. Global changes to the ubiquitin system in Huntington's disease. Nature 2007, 448:704-708.
3. Bland C.S., Wang E.T., Vu A., David M.P., Castle J.C., Johnson J.M., Burge C.B., Cooper T.A. Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res. 2010, 38:7651-7664.
4. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 2009, 10:741-754.
5. Ciafaloni E., Mignot E., Sansone V., Hilbert J.E., Lin L., Lin X., Liu L.C., Pigeon W.R., Perlis M.L., Thornton C.A. The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology 2008, 70:226-230.
6. Cooper T.A., Wan L., Dreyfuss G. RNA and disease. Cell 2009, 136:777-793.
7. Cosgrove K.P., Mazure C.M., Staley J.K. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol. Psychiatry 2007, 62:847-855.
8. Daughters R.S., Tuttle D.L., Gao W., Ikeda Y., Moseley M.L., Ebner T.J., Swanson M.S., Ranum L.P. RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. 2009, 5:e1000600.
9. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
10. Du H., Cline M.S., Osborne R.J., Tuttle D.L., Clark T.A., Donohue J.P., Hall M.P., Shiue L., Swanson M.S., Thornton C.A., Ares M. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 2010, 17:187-193.
11. Emamian E.S., Kaytor M.D., Duvick L.A., Zu T., Tousey S.K., Zoghbi H.Y., Clark H.B., Orr H.T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 2003, 38:375-387.
12. Foster T.C., Rani A., Kumar A., Cui L., Semple-Rowland S.L. Viral vector-mediated delivery of estrogen receptor-alpha to the hippocampus improves spatial learning in estrogen receptor-alpha knockout mice. Mol. Ther. 2008, 16:1587-1593.
13. Fujiki N., Cheng T., Yoshino F., Nishino S. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice. Exp. Neurol. 2009, 217:46-54.
14. Goers E.S., Purcell J., Voelker R.B., Gates D.P., Berglund J.A. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res. 2010, 38:2467-2484.
15. Gomes-Pereira M., Foiry L., Nicole A., Huguet A., Junien C., Munnich A., Gourdon G. CTG trinucleotide repeat " big jumps": large expansions, small mice. PLoS Genet. 2007, 3:e52.
16. Han S., Nam J., Li Y., Kim S., Cho S.H., Cho Y.S., Choi S.Y., Choi J., Han K., Kim Y., et al. Regulation of dendritic spines, spatial memory, and embryonic development by the TANC family of PSD-95-interacting proteins. J. Neurosci. 2010, 30:15102-15112.
17. Hao M., Akrami K., Wei K., De Diego C., Che N., Ku J.H., Tidball J., Graves M.C., Shieh P.B., Chen F. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy. Dev. Dyn. 2008, 237:403-410.
18. Harper P.S. Myotonic Dystrophy 2001, WB Saunders, London. Third Edition.
19. Holt I., Jacquemin V., Fardaei M., Sewry C.A., Butler-Browne G.S., Furling D., Brook J.D., Morris G.E. Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. Am. J. Pathol. 2009, 174:216-227.
20. Jensen K.B., Darnell R.B. CLIP: crosslinking and immunoprecipitation of in vivo RNA targets of RNA-binding proteins. Methods Mol. Biol. 2008, 488:85-98.
21. Jiang H., Mankodi A., Swanson M.S., Moxley R.T., Thornton C.A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 2004, 13:3079-3088.
22. Kalsotra A., Cooper T.A. Functional consequences of developmentally regulated alternative splicing. Nat. Rev. Genet. 2011, 12:715-729.
23. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
24. Kanadia R.N., Shin J., Yuan Y., Beattie S.G., Wheeler T.M., Thornton C.A., Swanson M.S. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl. Acad. Sci. USA 2006, 103:11748-11753.
25. Klassen T., Davis C., Goldman A., Burgess D., Chen T., Wheeler D., McPherson J., Bourquin T., Lewis L., Villasana D., et al. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 2011, 145:1036-1048.
26. Koshelev M., Sarma S., Price R.E., Wehrens X.H., Cooper T.A. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1. Hum. Mol. Genet. 2010, 19:1066-1075.
27. Kuyumcu-Martinez N.M., Wang G.S., Cooper T.A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell 2007, 28:68-78.
28. Ladd A.N., Stenberg M.G., Swanson M.S., Cooper T.A. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev. Dyn. 2005, 233:783-793.
29. Li Q., Lee J.A., Black D.L. Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 2007, 8:819-831.
30. Licatalosi D.D., Darnell R.B. RNA processing and its regulation: global insights into biological networks. Nat. Rev. Genet. 2010, 11:75-87.
31. Licatalosi D.D., Mele A., Fak J.J., Ule J., Kayikci M., Chi S.W., Clark T.A., Schweitzer A.C., Blume J.E., Wang X., et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008, 456:464-469.
32. Lin X., Miller J.W., Mankodi A., Kanadia R.N., Yuan Y., Moxley R.T., Swanson M.S., Thornton C.A. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 2006, 15:2087-2097.
33. Llorian M., Schwartz S., Clark T.A., Hollander D., Tan L.Y., Spellman R., Gordon A., Schweitzer A.C., de la Grange P., Ast G., Smith C.W. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat. Struct. Mol. Biol. 2010, 17:1114-1123.
34. López Castel A., Nakamori M., Tomé S., Chitayat D., Gourdon G., Thornton C.A., Pearson C.E. Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues. Hum. Mol. Genet. 2011, 20:1-15.
35. Lüttjohann A., Fabene P.F., van Luijtelaar G. A revised Racine's scale for PTZ-induced seizures in rats. Physiol. Behav. 2009, 98:579-586.
36. McKinney B.C., Sze W., Lee B., Murphy G.G. Impaired long-term potentiation and enhanced neuronal excitability in the amygdala of Ca(V)1.3 knockout mice. Neurobiol. Learn. Mem. 2009, 92:519-528.
37. Meola G., Sansone V. Cerebral involvement in myotonic dystrophies. Muscle Nerve 2007, 36:294-306.
38. Modoni A., Silvestri G., Vita M.G., Quaranta D., Tonali P.A., Marra C. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study. J. Neurol. 2008, 255:1737-1742.
39. Ni J.Z., Grate L., Donohue J.P., Preston C., Nobida N., O'Brien G., Shiue L., Clark T.A., Blume J.E., Ares M. Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev. 2007, 21:708-718.
40. Osborne R.J., Lin X., Welle S., Sobczak K., O'Rourke J.R., Swanson M.S., Thornton C.A. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum. Mol. Genet. 2009, 18:1471-1481.
41. Pal R., Agbas A., Bao X., Hui D., Leary C., Hunt J., Naniwadekar A., Michaelis M.L., Kumar K.N., Michaelis E.K. Selective dendrite-targeting of mRNAs of NR1 splice variants without exon 5: identification of a cis-acting sequence and isolation of sequence-binding proteins. Brain Res. 2003, 994:1-18.
42. Pincherle A., Patruno V., Raimondi P., Moretti S., Dominese A., Martinelli-Boneschi F., Pasanisi M.B., Canioni E., Salerno F., Deleo F., et al. Sleep breathing disorders in 40 Italian patients with Myotonic dystrophy type 1. Neuromuscul. Disord. 2012, 22:219-224.
43. Poulos M.G., Batra R., Charizanis K., Swanson M.S. Developments in RNA splicing and disease. Cold Spring Harb. Perspect. Biol. 2011, 3:a000778.
44. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
45. Romeo V., Pegoraro E., Ferrati C., Squarzanti F., Sorarù G., Palmieri A., Zucchetta P., Antunovic L., Bonifazi E., Novelli G., et al. Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J. Neurol. 2010, 257:1246-1255.
46. Sergeant N., Sablonnière B., Schraen-Maschke S., Ghestem A., Maurage C.A., Wattez A., Vermersch P., Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 2001, 10:2143-2155.
47. Shimizu E., Tang Y.P., Rampon C., Tsien J.Z. NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation. Science 2000, 290:1170-1174.
48. Sicot G., Gourdon G., Gomes-Pereira M. Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges. Hum. Mol. Genet. 2011, 20(R2):R116-R123.
49. Suenaga K., Lee K.Y., Nakamori M., Tatsumi Y., Takahashi M.P., Fujimura H., Jinnai K., Yoshikawa H., Du H., Ares M., et al. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. PLoS ONE 2012, 7:e33218.
50. Sugnet C.W., Srinivasan K., Clark T.A., O'Brien G., Cline M.S., Wang H., Williams A., Kulp D., Blume J.E., Haussler D., Ares M. Unusual intron conservation near tissue-regulated exons found by splicing microarrays. PLoS Comput. Biol. 2006, 2:e4.
51. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
52. Ward A.J., Rimer M., Killian J.M., Dowling J.J., Cooper T.A. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum. Mol. Genet. 2010, 19:3614-3622.
53. Weber Y.G., Roebling R., Kassubek J., Hoffmann S., Rosenbohm A., Wolf M., Steinbach P., Jurkat-Rott K., Walter H., Reske S.N., et al. Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology 2010, 74:1108-1117.
54. Witten J.T., Ule J. Understanding splicing regulation through RNA splicing maps. Trends Genet. 2011, 27:89-97.
55. Xue Y., Zhou Y., Wu T., Zhu T., Ji X., Kwon Y.S., Zhang C., Yeo G., Black D.L., Sun H., et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol. Cell 2009, 36:996-1006.
56. Yamamoto H., Kokame K., Okuda T., Nakajo Y., Yanamoto H., Miyata T. NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia. J. Biol. Chem. 2011, 286:26158-26165.
57. Yu H., Laberge L., Jaussent I., Bayard S., Scholtz S., Raoul M., Pages M., Dauvilliers Y. Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study. Sleep 2011, 34:165-170.
58. Zhang C., Darnell R.B. Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat. Biotechnol. 2011, 29:607-614.
59. Zhang C., Zhang Z., Castle J., Sun S., Johnson J., Krainer A.R., Zhang M.Q. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 2008, 22:2550-2563.
60. Zu T., Gibbens B., Doty N.S., Gomes-Pereira M., Huguet A., Stone M.D., Margolis J., Peterson M., Markowski T.W., Ingram M.A., et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. USA 2011, 108:260-265.